FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
 OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Moriarty Thomas M		 2. Issuer Name and Ticker or Trading Symbol

CVS HEALTH Corp [ CVS ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                    _____ 10% Owner
__X__ Officer (give title below)    _____ Other (specify below)
EVP & General Counsel
(Last)          (First)          (Middle)

ONE CVS DRIVE		 3. Date of Earliest Transaction (MM/DD/YYYY)

12/31/2022
(Street)

WOONSOCKET, RI 02895
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
 6. Individual or Joint/Group Filing (Check Applicable Line)

_X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 12/31/2022  F  292856 (1)D$93.19 315273.0221 D  
Common Stock         159120 I By GRAT 
Stock Unit         47325.339 D  

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)		2. Conversion or Exercise Price of Derivative Security3. Trans. Date3A. Deemed Execution Date, if any4. Trans. Code
(Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)		8. Price of Derivative Security
(Instr. 5)		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option $104.82           4/1/2017 (2)4/1/2023 Common Stock 71696  71696 D  
Stock Option $78.05           4/3/2018 (3)4/3/2024 Common Stock 24248  24248 D  
Stock Option $54.19           4/1/2020 (4)4/1/2029 Common Stock 50502  50502 D  
Stock Option $58.34 (5)          4/1/2021 (6)4/1/2030 Common Stock 98558  98558 D  
Stock Option (7)$74.30           4/1/2022 4/1/2031 Common Stock 116622  116622 D  
Stock Option $101.09           4/1/2023 (8)4/1/2032 Common Stock 46777  46777 D  
Explanation of Responses:
(1) Surrender of shares in payment of withholding taxes due upon the vesting and settlement of the PSUs.
(2) Option became exercisable in four equal annual installments, commencing 4/1/2017.
(3) Option became exercisable in four equal annual installments, commencing 4/3/2018.
(4) Option became exercisable in four equal annual installments, commencing 4/1/2020.
(5) The number of shares subject to the option were calculated using a 30-day average price.
(6) Option became exercisable in four equal annual installments, commencing 4/1/2021.
(7) Option became exercisable in four equal annual installments, commencing 4/1/2022.
(8) Option becomes exercisable in four equal annual installments, commencing 4/1/2023.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director10% OwnerOfficerOther
Moriarty Thomas M
ONE CVS DRIVE
WOONSOCKET, RI 02895

EVP & General Counsel
Signatures
/s/ Thomas M. Moriarty1/4/2023
**Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
*If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note:File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
CVS Health (NYSE:CVS)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024 Click aqui para mais gráficos CVS Health.
CVS Health (NYSE:CVS)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024 Click aqui para mais gráficos CVS Health.